Next-Generation Sequencing Panels Preauthorization
Upon receipt of a preauthorization request, an email will be sent to ordering provider or contact person listed on preauthorization form. To check the status of your patient's preauthorization, call 855.320.4869 or email firstname.lastname@example.org.
First, the preauthorization team will obtain benefits information and out-of-pocket estimate. Next, many cases will need medical review to confirm patient meets medical necessity criteria established by insurance payer; this can take a week or more. Once the preauthorization process is complete, out-of-pocket estimate is shared with provider, or if preferred, directly with the patient. Lastly, before testing begins, the ordering provider and/or patient must contact the preauthorization team to release the sample for testing.
Preauthorizations are handled in the order the requests are received. To expedite your preauthorization request, be sure to include:
- Preauthorization form
- Enlarged copy of patient's insurance card
- ABN, when applicable
- Supporting clinical documentation, such as clinic notes, pedigree, and/or letter of medical necessity
Templates for letter of medical necessity are available for the BROCA and ColoSeq™ Cancer Risk Panels. To receive the most up-to-date template, email a request to email@example.com.
University of Washington is able to bill Medicaid in some states. To see if Laboratory Medicine is able to bill Medicaid in your state, contact us at firstname.lastname@example.org.
BROCA Cancer Risk Panel is covered for patients who meet Medicare genetic testing criteria for BRCA1/2, Lynch syndrome, or APC and MUTYH testing.
ColoSeq™ is covered for patients who meet Medicare genetic testing criteria for Lynch syndrome.
If BRCA1/2 testing has already been done and patient does not meet Medicare criteria for other genetic testing, an ABN is required. Similarly, if testing for Lynch syndrome or familial polyposis has already been done and patient does not meet Medicare criteria for other genetic testing, an ABN is required.
Patients that are covering the entire cost of testing out-of-pocket may be eligible for a discount, if they pay for services in advance.
- Other tests offered by the Genetics and Solid Tumor Diagnostic Laboratory
- Lab telephone: 206.598.6429
- Supervisor: Robert Livingston, PhD
- Genetic Counselor: Angela Jacobson, MS, CGC
- Genetic Counselor: Sarah Paolucci, MS, CGC
- Genetic Counselor: Ginger Tsai, MS, CGC
- Director: Colin C. Pritchard, MD, PhD
- Director: Karen Stephens, PhD
- Director: Jonathan Tait, MD, PhD
|BRCA12||BRCA1&2 Analysis||Peripheral Blood, cultured cells from sk...|
|BROCA||BROCA Cancer Risk Panel||Peripheral Blood, cultured cells from sk...|
|COSEQ||ColoSeq - Lynch and Polyposis Panel||ColoSeq™ : Peripheral Blood or purified ...|
|COSEQP||ColoSeq _ Polyposis||Peripheral Blood, purified DNA from peri...|
|CSQTP||ColoSeq Tumor Panel||Formalin-Fixed Paraffin Embedded Tumor T...|
|CSQTS||ColoSeq Tumor Single Gene||Formalin-Fixed Paraffin Embedded Tumor T...|
|EPIPX||Epileptic Encephalopathy Panel||Peripheral Blood, cultured cells from sk...|
|IMD||Immunoplex Panel||Peripheral Blood, cultured cells from sk...|
|MEGPX||Megalencephaly Panel||Skin biopsy/Cultured fibroblasts, FFPE T...|
|MRW||MarrowSeq™ Hereditary Bone Marrow Failure Panel||Peripheral Blood, cultured cells from sk...|
|OPG||UW-OncoPlex Single Gene||Tumor Tissue, Purified DNA, Bone Marrow,...|
|OPX||UW OncoPlex Cancer Gene Panel||Tumor Tissue, Purified DNA, Bone Marrow,...|
|SGN||Single Gene Analysis||Peripheral Blood, cultured cells from sk...|
Last updated 2019-10-28T20:58:18.493134+00:00